GLP 1 Weight Loss Drugs and Gut Problems
US$ 27.57
what does glp-1 actually do for Weight Loss and Diabetes Frontiers | GLP−1 receptor agonists
Description
The data available for exenatide showed less of a risk towards thyroid cancer than liraglutide, but to better quantify the risk the FDA has required Amylin to conduct additional rodent studies to better identify the thyroid issue
received speaking honoraria from Abbott Diabetes Care, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Dexcom, GSK, Eli Lilly and Company, HLS Therapeutics, Insulet, Janssen, Novo Nordisk, Pfizer, and Sanofi
This event has passed
This evidence prompted medical societies (such as the American Diabetes Association) to include GLP-1 in their diabetes care recommendations
